BioWorld MedTech

April 13, 2015

Are patient-reported outcomes getting lost in translation?

Analysis shows V-Go helps reduce Type 2 diabetes management cost

MDD's Stock Report: Winners and Losers

HIT Bits: Dexcom develops CGM solution for Apple Watch

Grants: United Health Foundation gives TPCA $900,000 funding for telehealth

Direct Flow Medical gains patient expansion approval in SALUS trial

Direct Flow Medical (Santa Rosa, California) said it has received FDA approval to broaden its SALUS trial including the addition of high risk patients and randomization against Medtronic's (Dublin) CoreValve. Read More

Report from Asia: China steps up efforts to regulate IVD reagents market

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

Gene replacement rescues autism-related phenotypes in mice

BioWorld Science

Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...

For clonal hematopoiesis, epigenetics can be in driver’s seat

BioWorld Science

Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...

Illustration of amyloid plaques in Alzheimer's disease

Elixiron’s enrupatinib shows upbeat interim phase II AD results